Triamcinolone injection in frontal sinus surgery

Comparison of results of frontal sinus surgery with direct injection of Corticosteroid (Triamcinolone) and foam gel containing Corticosteroid (Triamcinolone)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211218053446N1

Enrollment

Registered

2021-12-28

Start date

2022-01-05

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis. Chronic sinusitis, unspecified

Interventions

Intervention 1: Intervention group: Triamcinolone impregnated gel foam nasal dressing. Intervention 2: Control group: Topical injection of Triamcinolone.

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age of 18 to 65 years Chronic rhinosinusitis as defined by the American Academy of Otolaryngology patients have proved rhinosinusitis by CT-scan

Exclusion criteria

Exclusion criteria: Patients who are taking daily corticosteroid drugs Pregnant patient Existence of any polyp in the nasal cavity Patient unwillingness to continue participating in clinical trial

Design outcomes

Primary

Measure	Time frame
Inflammation. Timepoint: 1 month, 3 months, 6 months. Method of measurement: Physical Examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mehrnoush Mousavi Aghdas

Tabriz University of Medical Sciences

mehr_mousavi@yahoo.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026